Lippa A - Search Results

1

DOV 216,303, a "triple" reuptake inhibitor: safety, tolerability, and pharmacokinetic profile.

Beer B, Stark J, Krieter P, Czobor P, Beer G, Lippa A, Skolnick P. Beer B, et al. Among authors: lippa a. J Clin Pharmacol. 2004 Dec;44(12):1360-7. doi: 10.1177/0091270004269560. J Clin Pharmacol. 2004. PMID: 15545306 Clinical Trial.

2

Preclinical and clinical pharmacology of DOV 216,303, a "triple" reuptake inhibitor.

Skolnick P, Krieter P, Tizzano J, Basile A, Popik P, Czobor P, Lippa A. Skolnick P, et al. Among authors: lippa a. CNS Drug Rev. 2006 Summer;12(2):123-34. doi: 10.1111/j.1527-3458.2006.00123.x. CNS Drug Rev. 2006. PMID: 16958986 Free PMC article. Review.

3

Antidepressant-like actions of DOV 21,947: a "triple" reuptake inhibitor.

Skolnick P, Popik P, Janowsky A, Beer B, Lippa AS. Skolnick P, et al. Among authors: lippa as. Eur J Pharmacol. 2003 Feb 14;461(2-3):99-104. doi: 10.1016/s0014-2999(03)01310-4. Eur J Pharmacol. 2003. PMID: 12586204

4

"Broad spectrum" antidepressants: is more better for the treatment of depression?

Skolnick P, Popik P, Janowsky A, Beer B, Lippa AS. Skolnick P, et al. Among authors: lippa as. Life Sci. 2003 Nov 7;73(25):3175-9. doi: 10.1016/j.lfs.2003.06.007. Life Sci. 2003. PMID: 14561522 Review.

5

Anxioselective anxiolytics: can less be more?

Basile AS, Lippa AS, Skolnick P. Basile AS, et al. Eur J Pharmacol. 2004 Oct 1;500(1-3):441-51. doi: 10.1016/j.ejphar.2004.07.043. Eur J Pharmacol. 2004. PMID: 15464051 Review.

6

Characterization of the antinociceptive actions of bicifadine in models of acute, persistent, and chronic pain.

Basile AS, Janowsky A, Golembiowska K, Kowalska M, Tam E, Benveniste M, Popik P, Nikiforuk A, Krawczyk M, Nowak G, Krieter PA, Lippa AS, Skolnick P, Koustova E. Basile AS, et al. Among authors: lippa as. J Pharmacol Exp Ther. 2007 Jun;321(3):1208-25. doi: 10.1124/jpet.106.116483. Epub 2007 Feb 26. J Pharmacol Exp Ther. 2007. PMID: 17325229

7

Selective anxiolysis produced by ocinaplon, a GABA(A) receptor modulator.

Lippa A, Czobor P, Stark J, Beer B, Kostakis E, Gravielle M, Bandyopadhyay S, Russek SJ, Gibbs TT, Farb DH, Skolnick P. Lippa A, et al. Proc Natl Acad Sci U S A. 2005 May 17;102(20):7380-5. doi: 10.1073/pnas.0502579102. Epub 2005 May 3. Proc Natl Acad Sci U S A. 2005. PMID: 15870187 Free PMC article. Clinical Trial.

8

Pharmacological profile of the "triple" monoamine neurotransmitter uptake inhibitor, DOV 102,677.

Popik P, Krawczyk M, Golembiowska K, Nowak G, Janowsky A, Skolnick P, Lippa A, Basile AS. Popik P, et al. Among authors: lippa a. Cell Mol Neurobiol. 2006 Jul-Aug;26(4-6):857-73. doi: 10.1007/s10571-006-9012-5. Epub 2006 Apr 25. Cell Mol Neurobiol. 2006. PMID: 16636898

9

A multicenter, placebo-controlled, double-blind, randomized study of efficacy and safety of ocinaplon (DOV 273,547) in generalized anxiety disorder.

Czobor P, Skolnick P, Beer B, Lippa A. Czobor P, et al. Among authors: lippa a. CNS Neurosci Ther. 2010 Apr;16(2):63-75. doi: 10.1111/j.1755-5949.2009.00109.x. Epub 2009 Dec 22. CNS Neurosci Ther. 2010. PMID: 20041911 Free PMC article. Clinical Trial.

10

Introduction. Overview of citalopram.

Lippa AS, Beer B, Cancro R. Lippa AS, et al. J Clin Psychopharmacol. 1999 Oct;19(5 Suppl 1):1S-3S. doi: 10.1097/00004714-199910001-00001. J Clin Psychopharmacol. 1999. PMID: 10507504 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

120 results

Search Page

Filters